Related Experiment Video
Updated: Aug 9, 2026

Protocol for Culturing Sympathetic Neurons from Rat Superior Cervical Ganglia (SCG)
Published on: January 30, 2009
Nerve growth factor prevents apoptotic cell death in injured central cholinergic neurons
B J Wilcox1, M D Applegate, C Portera-Cailliau
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, Maryland 21205, USA.
Abstract:
Experimental lesions have been widely used to induce neuronal degeneration and to test the ability to trophic molecules to prevent lesion-induced alterations, but these studies have not demonstrated unequivocally that afflicted neurons die as a result of these manipulations. The documentation of neuronal death in the above-described models and the time when it occurs after injury are crucial for the interpretation of trophic effects. In the present study, we combined multiple approaches to investigate the nature of retrograde neuronal changes in cholinergic neurons of the medial septal nucleus (MSN) after complete, unilateral transection of the fimbria-fornix (F-F). Projections neurons of the MSN were prelabeled with the fluorescent tracer Fluoro-gold (FG) 1 week prior to lesion. By counting both FG-labeled and choline acetyltransferase (ChAT)-immunoreactive neurons in the MSN at multiple time points postaxotomy, we differentiated the phenotypic response to injury from the degenerative process and established a critical time between the third and fourth weeks postaxotomy, during which approximately 50% of fluorescent perikarya disappear. Working in the previous time window, we identified dying cells by electron microscopy (EM) and terminal transferase-mediated (TdT) deoxyuridine triphosphate (d-UTP)-biotin nick end labeling (TUNEL) and showed that MSN neurons die via apoptosis, beginning at 16 days postaxotomy. An additional group of animals was allowed to survive for 1 month (i.e., 10 days after cell death has been completed); during this period, animals were treated with intraventricular nerve growth factor (NGF). Quantitative analysis of surviving cholinergic perikarya showed that NGF prevented degeneration of the majority of neurons. In concert, the results of the present study establish that NGF does not merely protect the phenotype but also prevents cell death in lesioned central cholinergic neurons.
Insights
Nerve Growth Factor (NGF) prevents cell death in injured central cholinergic neurons by inhibiting apoptosis. This study confirms NGF
Area of Science:
- Neuroscience
- Cell Biology
Background:
- Experimental lesions are used to study neuronal degeneration and trophic molecule effects.
- Previous studies lacked definitive proof of lesion-induced neuronal death.
Purpose of the Study:
- To investigate retrograde neuronal changes in medial septal nucleus (MSN) cholinergic neurons after fimbria-fornix (F-F) transection.
- To determine the timing and mechanism of neuronal death.
- To assess the neuroprotective effect of Nerve Growth Factor (NGF).
Main Methods:
- Combined Fluoro-gold (FG) labeling, choline acetyltransferase (ChAT) immunohistochemistry, electron microscopy (EM), and TUNEL assay.
- Quantified FG-labeled and ChAT-immunoreactive neurons at multiple time points post-lesion.
- Administered intraventricular NGF to a subset of animals.
Main Results:
- Neuronal death in MSN cholinergic neurons occurred via apoptosis, starting at 16 days postaxotomy.
- Approximately 50% of neurons disappeared between weeks 3 and 4 post-lesion.
- NGF treatment prevented the degeneration of the majority of cholinergic neurons.
Conclusions:
- NGF administration significantly prevents cell death in lesioned central cholinergic neurons.
- NGF's protective effect extends beyond phenotypic preservation to include the prevention of apoptosis.
- This study provides critical data on the timing of neuronal death and the efficacy of NGF in a central nervous system injury model.

